Month: June 2024

Multitude SE: Approval of written procedure and amendments to the terms and conditions of its senior bonds due 2025 Multitude SE (the “Company“) today announces the successful completion of the written procedure that was initiated on 16 May 2024 in relation to the Company’s senior unsecured floating rate bonds with ISIN NO0012702549 (the “Bonds“), regarding certain amendments to the terms and conditions of the Bonds (the “Proposal“). A sufficient number of bondholders participated in the written procedure in order to form a quorum, and a requisite majority of the bondholders voted in favour of approving the Proposal. The amendments will become effective when the Company and the agent enter into an amendment and restatement agreement, amending and restating the terms and conditions of the Bonds...

Multitude SE: Approval of written procedure and amendments to the terms and conditions of its subordinated capital notes Multitude SE (the “Company“) today announces the successful completion of the written procedure that was initiated on 16 May 2024 in relation to the Company’s subordinated perpetual floating rate callable capital notes with ISIN NO0011037327 (the “Notes“), regarding certain amendments to the terms and conditions of the Notes (the “Proposal“). A sufficient number of noteholders participated in the written procedure in order to form a quorum, and a requisite majority of the noteholders voted in favour of approving the Proposal. The amendments will become effective when the Company and the agent enter into an amendment and restatement agreement, amending and restating the terms...

DENVER, June 11, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that its patented, cell-directed, extracorporeal Selective Cytopheretic Device (SCD) is being featured in two presentations at the 42nd Vicenza Course AKI-CRRT-ECOS and Critical Care Nephrology conference today, June 11, 2024. The International Vicenza Course – a scientific program that integrates industry-sponsored symposia, meet-the-expert sessions and short presentations – is being held June 11-13 in Vicenza, Italy. “The prestigious International Vicenza Course is known for showcasing breakthroughs in the field of extracorporeal organ support. It is an honor to be invited to showcase our...

PALI-2108 is orally delivered and colon-specific allowing for local activity with low systemic exposure Company on track to commence Phase 1 human clinical study of PALI-2108 for the treatment of UC before year end Carlsbad, CA, June 11, 2024 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that the Canadian Intellectual Property Office (CIPO) has issued a Notice of Allowance for patent application number 3,174,137 titled, “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors.” This patent covers the composition of PALI-2108, the Company’s orally administered, locally acting colon-specific Phosphodiesterase-4 (PDE4) inhibitor...

SAN DIEGO, CA, June 11, 2024 (GLOBE NEWSWIRE) — – Spin-out is in process with a final plan expected by 30 June 2024 – Regreen founder to return 10 million shares to Astra treasury This follows recent News article: Astra Energy Inc. Enters Material Definitive Agreement for Power Generation in the Digital Coin Mining and Data Center Marketplace Astra Energy Inc.(OTCQB: ASRE) (“Astra” or the “Company”) would like to provide a shareholder update on the spin-out of Regreen Technologies Inc. (“Regreen”). On Sept. 06, 2023, Astra announced that it would commence the process of spinning out its subsidiary Regreen into an existing entity on a U.S. exchange or listing it on a U.S. exchange with an accompanying IPO. On March 8, 2024, Astra announced the closing of a joint venture transaction with Powertron Global LLC...

Marking the Second Consecutive Year of Stevie® Recognition EL MONTE, Calif., June 11, 2024 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced its recognition as a Silver Stevie® Award winner in the “Achievement in Growth” category of the 2024 American Business Awards®. This accomplishment marks the second straight year the Company has been honored with a Stevie® Award, underscoring its commitment to growth and innovation. Last year, GigaCloud received a Bronze Stevie® Award in the category of “Fastest Growing Company of the Year.” Other recipients of the Stevie® Awards include IBM, Samsung Electronics America, and Fidelity Investments. “We are thrilled to be a Stevie® Award winner two years...

– Topline data expected in December 2024 – – Phase 2b design optimized for success; clear path to market in this high value indication expected with positive result – BOSTON, June 11, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that it has completed enrollment in RewinD-LB, a Phase 2b trial evaluating neflamapimod in patients with dementia with Lewy bodies (DLB). “Drug development for the major dementias over the past decade has progressively focused on earlier stages of disease. In our phase 2a data with neflamapimod in patients with DLB, the treatment response in patients with pure DLB was substantial and greater than the response seen in patients who had biomarker evidence of Alzheimer’s...

Net Sales Decline (1.4)%; Comparable Sales Decline (5.7)% GAAP Diluted EPS of $1.01, or $1.08 Adjusted Diluted EPS Opened Two New Stores During the First Quarter Returned $132 Million to Shareholders Through Share Repurchases and Dividends KATY, Texas, June 11, 2024 (GLOBE NEWSWIRE) — Academy Sports and Outdoors, Inc. (Nasdaq: ASO) (“Academy” or the “Company”) today announced its financial results for the first quarter ended May 4, 2024. Steve Lawrence, Chief Executive Officer, commented, “As expected, our first quarter results reflect that our customers remain under pressure in the current economic environment. We will navigate through the remainder of the year by continuing to lean into our position as the value leader in our space, while also inspiring customers to shop through introductions and...